PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies - Normandie Université Access content directly
Journal Articles Cancers Year : 2017

PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies

Anne Perdrix
Génétique du cancer et des maladies neuropsychiatriques
Ahmad Najem
  • Function : Author
Sven Saussez
  • Function : Author
  • PersonId : 910399
Laboratory of Anatomy
Ahmad Awada
  • Function : Author
Clinique d'Oncologie Médicale [Brussels, Belgium]
Fabrice Journe
  • Function : Author
  • PersonId : 869723
Institut Jules Bordet [Bruxelles]
Ghanem Ghanem
  • Function : Author
  • PersonId : 913435
Laboratoire d'Oncologie et de Chirurgie Expérimentale
Mohammad Krayem
  • Function : Author

Domains

Cancer

Anne Perdrix  : Connect in order to contact the contributor

https://hal-normandie-univ.archives-ouvertes.fr/hal-02362393

Submitted on : Wednesday, November 13, 2019-7:10:30 PM

Last modification on : Wednesday, November 3, 2021-6:20:36 AM

Consult the full text

Dates and versions

hal-02362393 , version 1 (13-11-2019)

Identifiers

Cite

Anne Perdrix, Ahmad Najem, Sven Saussez, Ahmad Awada, Fabrice Journe, et al.. PRIMA-1 and PRIMA-1Met (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies. Cancers, 2017, 9 (12), pp.172. ⟨10.3390/cancers9120172⟩. ⟨hal-02362393⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

COMUE-NORMANDIE UNIROUEN
15 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More